White Papers / Tech Papers
-
Drug Delivery | Injectables | Scale-up/Technology Transfer
Selecting a CMO Partner for Sterile Injectable Manufacturing
Jubilant HollisterStier’s Value Proposition for CustomersReleased by: Jubilant HollisterStier CMO
-
Facilities
Get Paid for Surplus and Idle Equipment
Get paid for surplus and idle equipment, clean up your workspaces and reduce response time for things needed in production, all at the same time.Released by: Federal Equipment Company
-
Drug Development | Formulation Development
The Developability Classification System (DCS)
Enabling an Optimized Approach for Formulation of Poorly Soluble MoleculesReleased by: Merck
-
Capsules | Drug Development | Formulation Development | Scale-up/Technology Transfer
Quickly Create Custom Oral Delivery Systems And Reduce Time To Market With Adaptdose™
Adare's Adaptdose™ technology can help streamline your project's development time and help get you to market faster.Released by: Adare Pharma Solutions
-
Drug Development | Scale-up/Technology Transfer
Finding the Right CDMO Partner for Tech Transfer
Avoid Risks and Delays in Bringing your Drug to MarketReleased by: Emergent CDMO
-
Excipients
The Viscosity Reduction Platform: Viscosity-reducing excipients for protein formulation
This white paper evaluates the viscosity-reducing capacities of excipients and excipient combinations.Released by: MilliporeSigma
-
IDT Biologika Paper on Viral Vectors and Vaccines
Viral Vectors, Vaccines - A New Era of Collaborative DesignReleased by: IDT Biologika
-
IDT Biologika Paper on Expanding Viral Vectors
Smart Scale-Up: Expanding Viral Vectors With Microcarrier Bead TechnologyReleased by: IDT Biologika
-
IDT Biologika Paper on Developing Oncolytic Viruses
Best Practices For Oncolytic Virus Design, Development, and ManufacturingReleased by: IDT Biologika
-
Biologics, Proteins, Vaccines | Drug Development | Formulation Development
Expanding Octet® Applications in Downstream Biologics Characterization
Stability, Formulations and Aggregation StudiesReleased by: Sartorius Stedim North America Inc
-
The Viscosity Reduction Platform: Viscosity-Reducing Excipients for Protein Formulation
Protein viscosity is one of the major obstacles in preparing highly concentrated protein formulations. This white paper evaluates viscosity-reducing capacities.Released by: Merck
-
APIs | Solid Dosage/Semi-solids
HPAPI Drug Solid Oral Dosage (Sod) Manufacturing – Power, Precision and Productivity
How to Ensure Your CDMO Partner Has the Experience and Expertise to Get Your HPAPI Product Across the Finish Line.Released by: Enteris BioPharma
-
Clinical Trials
5 Ways that Decentralized Clinical Trial Approaches Can Reduce Study Costs
The use of decentralized clinical trials is on the rise. Read THREAD's report on 5 ways to reduce study costs.
-
Applications of Liquid-Filled Capsules for Challenging APIs
LFCs offer significant benefits for APIs that present formulation or manufacturing challenges, such as poor water solubility and bioavailability.Released by: Altasciences
-
Strategies to Successfully Transfer & Scale Rx & OTC Drugs
Bora’s Technology Transfer Whitepaper will help you discover key strategies to successfully transfer and scale Rx & OTC drugs.Released by: Bora Pharmaceuticals
-
Biologics, Proteins, Vaccines | Drug Development
How to Speed Up Vaccine Development and Production With Genetic Vaccine Technology
We explore the challenges and pitfalls in developing new genetic vaccines, and in manufacturing them following approval.Released by: Recipharm
-
APIs | Drug Development
Access the Advantages of Spray Drying with an Experienced API CDMO
Spray drying is experiencing huge demand as the number of poorly soluble small molecule drugs grows.Released by: Wavelength Pharmaceuticals
-
APIs | Formulation Development
Microspheres and Nanoparticles for Peptide Delivery
Navigating The Benefits And Challenges Of Microspheres And Nanoparticles For Peptide Delivery.Released by: Bachem
-
Drug Development | Scale-up/Technology Transfer | Validation
Keys to Successful Tech Transfer for Topical Pharmaceuticals
This whitepaper illustrates the keys to choosing the right manufacturing partner and how to manage a topical drug tech transfer.Released by: Tergus Pharma
-
APIs | Cytotoxics and High Potency Manufacturing | Drug Development
Leverage the Benefits of Biocatalysis with the Right API CDMO
A powerful tool for organic synthesis, enzymatic chemistry has become an established methodology for manufacturing APIs.Released by: Wavelength Pharmaceuticals
